Xilio Therapeutics, Inc.
SEC Filing List
XLO CIK: 0001840233
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 05/29/2026 | ||
| S-3/A | Amendment to Registration statement for ... | Xilio Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/27/2026 | |
| SCHEDULE 13G | SEWARD & KISSEL LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | SEWARD & KISSEL LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |||
| SCHEDULE 13G | Allen Overy Shearman Sterling LLP /fa | 05/15/2026 | |||
| 8-K | Current report filing | Xilio Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |
| S-3 | Registration statement for specified tra... | Xilio Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Xilio Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |
| ARS | Annual report to security holders | Xilio Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/28/2026 | |
| No record found. | |||||
| Load More | |||||
